NO20090368L - Cyanocobalamin lav viskositets vandige formuleringer for intranasal avlevering - Google Patents

Cyanocobalamin lav viskositets vandige formuleringer for intranasal avlevering

Info

Publication number
NO20090368L
NO20090368L NO20090368A NO20090368A NO20090368L NO 20090368 L NO20090368 L NO 20090368L NO 20090368 A NO20090368 A NO 20090368A NO 20090368 A NO20090368 A NO 20090368A NO 20090368 L NO20090368 L NO 20090368L
Authority
NO
Norway
Prior art keywords
cyanocobalamin
solution
csf
low viscosity
aqueous formulations
Prior art date
Application number
NO20090368A
Other languages
English (en)
Norwegian (no)
Inventor
Steven Quay
Zenaida O Go
Peter C Aprile
Antony P Sileno
Original Assignee
Qol Medical Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qol Medical Llc filed Critical Qol Medical Llc
Publication of NO20090368L publication Critical patent/NO20090368L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20090368A 2006-06-23 2009-01-23 Cyanocobalamin lav viskositets vandige formuleringer for intranasal avlevering NO20090368L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/024685 WO2007149098A1 (en) 2006-06-23 2006-06-23 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery

Publications (1)

Publication Number Publication Date
NO20090368L true NO20090368L (no) 2009-03-23

Family

ID=38833714

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090368A NO20090368L (no) 2006-06-23 2009-01-23 Cyanocobalamin lav viskositets vandige formuleringer for intranasal avlevering

Country Status (10)

Country Link
EP (1) EP2035441A4 (de)
JP (1) JP5769924B2 (de)
KR (3) KR20090074722A (de)
CN (1) CN101600729A (de)
AU (1) AU2006344733B2 (de)
CA (1) CA2656823C (de)
IL (2) IL196038A (de)
NO (1) NO20090368L (de)
WO (1) WO2007149098A1 (de)
ZA (1) ZA200900191B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2686299T3 (es) * 2010-10-29 2018-10-17 Troikaa Pharmaceuticals Ltd Composiciones nasales de vitamina B12
EP3589269B1 (de) * 2017-03-02 2021-04-07 Dutch Renewable Energy B.V. Intranasale verabreichung von physiologisch aktiven stoffen
US20220111162A1 (en) * 2020-07-29 2022-04-14 Lido Ventures Llc Apparatus, system, and method for facilitating intranasal treatment of a patient

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218679B1 (de) * 1985-04-16 1991-12-11 Nastech Pharmaceutical Company, Inc. Aerosolmittel zur nasenverstäubung von vitamin b 12
US4724231A (en) * 1985-04-16 1988-02-09 Nastech Pharmaceutical, Inc. Nasel compositions containing vitamin B12
US5112804A (en) * 1987-04-01 1992-05-12 Temple University Of The Commonwealth System Of Higher Education Pharmaceutical composition and method of intranasal administration
US4959176A (en) * 1988-04-29 1990-09-25 Beckman Instruments, Inc. High resolution non corrosive amino acid analysis buffer solutions
US5227311A (en) * 1988-10-11 1993-07-13 Abbott Laboratories Intrinsic factor to determine B12
BE1007839A6 (nl) * 1993-12-20 1995-10-31 Merkus Franciscus W H M Prof Farmaceutische compositie voor de nasale toediening van hydroxocobalamine.
US6406730B1 (en) * 1998-12-01 2002-06-18 Carl E. Banyard Process for producing low acid food products
FR2787029A1 (fr) * 1998-12-09 2000-06-16 Biovector Therapeutics Utilisation dans une composition pharmaceutique pour l'administration par voie nasale de vitamine b12 pour la delivrance d'agents actifs au systeme nerveux central
US20040043043A1 (en) * 2000-09-20 2004-03-04 Schlyter Jimmy Hirschsprung Preparation of emulsions and concentrates thereof
US20060074034A1 (en) * 2001-09-17 2006-04-06 Collins Douglas A Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof
US6911434B2 (en) * 2002-02-04 2005-06-28 Corixa Corporation Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
DE10300719A1 (de) * 2003-01-11 2004-07-22 Basf Ag Verbessertes Verfahren zur Herstellung von Vitamin B12
US20060127320A1 (en) * 2004-05-10 2006-06-15 Nastech Pharmaceutical Company Inc. Method of delivering parathyroid hormone to a human
US20060046969A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Antibacterial compositions for drug administration
JP2009504767A (ja) * 2005-08-17 2009-02-05 フレミング・アンド・カンパニー・ファーマシューティカルズ ビタミンｂ１２鼻用スプレーおよび使用方法

Also Published As

Publication number Publication date
IL248447A0 (en) 2016-11-30
IL248447B (en) 2021-10-31
CA2656823A1 (en) 2007-12-27
IL196038A (en) 2016-10-31
KR20090074722A (ko) 2009-07-07
JP5769924B2 (ja) 2015-08-26
KR20170098977A (ko) 2017-08-30
JP2009541312A (ja) 2009-11-26
CA2656823C (en) 2015-02-03
EP2035441A1 (de) 2009-03-18
AU2006344733B2 (en) 2014-02-27
KR20140101010A (ko) 2014-08-18
EP2035441A4 (de) 2013-01-16
IL196038A0 (en) 2009-09-01
WO2007149098A1 (en) 2007-12-27
ZA200900191B (en) 2012-09-26
CN101600729A (zh) 2009-12-09
AU2006344733A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
AU2019257489A1 (en) Rapid establishment and/or termination of substantial steady-state drug delivery
UA92470C2 (ru) Стабильный при хранении инфузионный раствор дигидроптеридинонов
NO20054711L (no) Fremgangsmater og farmasoytiske blandinger for palitelig oppnaelse av akseptable serum-testosteronnivaer
WO2009105432A3 (en) Devices and methods for delivery of a therapeutic agent through a pneumostoma
JP2009504767A (ja) ビタミンｂ１２鼻用スプレーおよび使用方法
WO2004105702A3 (en) Foamable pharmaceutical compositions and methods for treating a disorder
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
MX2023006414A (es) Paquete de dosificacion unitaria y metodos para administrar medicaciones de perdida de peso.
WO2005012485A3 (en) Methods for treating diabetes and related disorders using pde10a inhibitors
WO2006039704A3 (en) Pharmaceutical composition and method for treating a joint capsule arthropathy
MY160074A (en) Protopanaxadiol-type ginsenoside compositions and uses thereof
BRPI0520493A2 (pt) usos de uma enzima, de um composto antifolato e de um agente de resgate de rota de folato, sistema terapêutico, e, métodos ex vivo para clivar um grupo l-glutamato terminal de um composto, para determinar a taxa e/ou extensão de clivagem de um composto e para clivar um composto
ATE475484T1 (de) Dosiervorrichtung
DK1883387T3 (da) Beholder til flydende medikamenter, der skal administreres
ZA200810124B (en) Pharmaceutical combination comprising 3-(3-dimethyl-amino-1-ethyl-2-methyl-propyl)-phenol and Paracetamol
NO20065453L (no) Fenoksyalkykarboksylsyrederivater i behandlingen av inflammatoriske sykdommer.
UA102254C2 (ru) Жидкий состав для деферипрона с приятным вкусом
PT2131810E (pt) Administração oral de uma calcitonina
UA102187C2 (ru) Фармацевтическая композиция для пероральной доставки дииндолилметана
NO20061417L (no) Syreinneholdende oxaliplatinformuleringer
MY144021A (en) Pharmaceutical delivery system
NO20090368L (no) Cyanocobalamin lav viskositets vandige formuleringer for intranasal avlevering
WO2009051217A1 (ja) フェンタニル含有経皮吸収製剤
WO2005020959A3 (en) Novel drug compositions and dosage forms of topiramate
BRPI0508053A (pt) método de combater toxicidade causada por um composto antifolato, e de tratar uma doença, usos de enzima que possui atividade de carbóxi-peptidase g, de composto antifolato, de agente de resgate de rota de folato, e de enzima que possui atividade de carbóxi-peptidase g e de um agente de resgate de rota de folato, sistema terapêutico, e, método ex vivo de clivar um grupo l-glutamato terminal de um composto, de determinar a taxa e/ou extenção de clivagem de um composto, e de clivagem de um composto

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ENDO PHARMACEUTICALS INC, US

FC2A Withdrawal, rejection or dismissal of laid open patent application